Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)

  1. Vukusic, S.
  2. Brassat, D.
  3. de Seze, J.
  4. Izquierdo, G.
  5. Lysandropoulos, A.
  6. Moll, W.
  7. Vanopdenbosch, L.
  8. Arque, M.J.
  9. Kertous, M.
  10. Rufi, P.
  11. Oreja-Guevara, C.
Revista:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Any de publicació: 2019

Volum: 29

Pàgines: 7-14

Tipus: Article

DOI: 10.1016/J.MSARD.2019.01.019 GOOGLE SCHOLAR
Font de les dades: Scopus